Sara Toffanin

Author PubWeight™ 32.51‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Lin28 promotes transformation and is associated with advanced human malignancies. Nat Genet 2009 6.35
2 Pivotal role of mTOR signaling in hepatocellular carcinoma. Gastroenterology 2008 4.03
3 Molecular classification and novel targets in hepatocellular carcinoma: recent advancements. Semin Liver Dis 2010 2.46
4 Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivo. J Hepatol 2009 2.42
5 Gene-expression signature of vascular invasion in hepatocellular carcinoma. J Hepatol 2011 2.39
6 Role of the microenvironment in the pathogenesis and treatment of hepatocellular carcinoma. Gastroenterology 2013 2.21
7 Personalized molecular targeted therapy in advanced, recurrent hepatocellular carcinoma after liver transplantation: a proof of principle. J Hepatol 2010 1.77
8 Notch signaling is activated in human hepatocellular carcinoma and induces tumor formation in mice. Gastroenterology 2012 1.71
9 IGF activation in a molecular subclass of hepatocellular carcinoma and pre-clinical efficacy of IGF-1R blockage. J Hepatol 2010 1.66
10 New strategies in hepatocellular carcinoma: genomic prognostic markers. Clin Cancer Res 2010 1.46
11 Wnt-pathway activation in two molecular classes of hepatocellular carcinoma and experimental modulation by sorafenib. Clin Cancer Res 2012 1.44
12 Induction of hepatocellular carcinoma by in vivo gene targeting. Proc Natl Acad Sci U S A 2012 1.31
13 Linking molecular classification of hepatocellular carcinoma and personalized medicine: preliminary steps. Curr Opin Oncol 2008 1.26
14 Combination therapy for hepatocellular carcinoma: additive preclinical efficacy of the HDAC inhibitor panobinostat with sorafenib. J Hepatol 2012 1.26
15 Patterns and changes in gene expression following neo-adjuvant anti-estrogen treatment in estrogen receptor-positive breast cancer. Endocr Relat Cancer 2008 0.81
16 microRNAs: new ways to block tumor angiogenesis? J Hepatol 2012 0.79